Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle, NC.
J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1580-1588. doi: 10.1016/j.jaip.2018.12.014. Epub 2018 Dec 21.
Nasal polyps influence the burden of aspirin-exacerbated respiratory disease (AERD) by contributing to eicosanoid production. AERD is diagnosed through graded aspirin challenges. It is not known how sinus surgery affects aspirin challenge outcomes.
To investigate the effects of endoscopic sinus surgery (ESS) on aspirin-induced reaction severity and on the levels of eicosanoids associated with these reactions.
Twenty-eight patients with AERD were challenged with aspirin before and 3 to 4 weeks after ESS. Respiratory parameters and plasma and urine levels of eicosanoids were compared before and after challenges.
Before ESS, AERD diagnosis was confirmed in all study patients by aspirin challenges that resulted in hypersensitivity reactions. After ESS, reactions to aspirin were less severe in all patients and 12 of 28 patients (43%, P < .001) had no detectable reaction. A lack of clinical reaction to aspirin was associated with lower peripheral blood eosinophilia (0.1 K/μL [interquartile range (IQR) 0.1-0.3] vs 0.4 K/μL [IQR 0.2-0.8]; P = .006), lower urinary leukotriene E levels after aspirin challenge (98 pg/mg creatinine [IQR 61-239] vs 459 pg/mg creatinine [IQR 141-1344]; P = .02), and lower plasma prostaglandin D to prostaglandin E ratio (0 [±0] vs 0.43 [±0.2]; P = .03), compared with those who reacted.
Sinus surgery results in decreased aspirin sensitivity and a decrease in several plasma and urine eicosanoid levels in patients with AERD. Diagnostic aspirin challenges should be offered to patients with suspected AERD before ESS to increase diagnostic accuracy. Patients with established AERD could undergo aspirin desensitizations after ESS as the severity of their aspirin-induced hypersensitivity reactions lessens.
鼻息肉通过促进类花生酸的产生而影响阿司匹林加重性呼吸系统疾病(AERD)的负担。AERD 通过分级阿司匹林挑战来诊断。目前尚不清楚鼻窦手术如何影响阿司匹林挑战的结果。
研究内镜鼻窦手术(ESS)对阿司匹林诱导反应严重程度以及与这些反应相关的类花生酸水平的影响。
对 28 例 AERD 患者进行了 ESS 前和 ESS 后 3-4 周的阿司匹林挑战。比较了挑战前后呼吸参数和血浆及尿液中类花生酸的水平。
在 ESS 之前,所有研究患者均通过阿司匹林挑战确认 AERD 诊断,这些挑战导致了过敏反应。ESS 后,所有患者对阿司匹林的反应均减轻,28 例患者中有 12 例(43%,P <.001)无反应可检测。对阿司匹林无临床反应与外周血嗜酸性粒细胞减少(0.1 K/μL[四分位距(IQR)0.1-0.3]与 0.4 K/μL[IQR 0.2-0.8];P =.006)、阿司匹林挑战后尿白三烯 E 水平降低(98 pg/mg 肌酐[IQR 61-239]与 459 pg/mg 肌酐[IQR 141-1344];P =.02)和血浆前列腺素 D 与前列腺素 E 比值降低(0[±0]与 0.43[±0.2];P =.03)相关。与反应者相比。
鼻窦手术导致 AERD 患者阿司匹林敏感性降低,并降低了几种血浆和尿液类花生酸水平。对于疑似 AERD 的患者,应在 ESS 前进行诊断性阿司匹林挑战,以提高诊断准确性。已经建立的 AERD 患者可以在 ESS 后进行阿司匹林脱敏治疗,因为他们的阿司匹林诱导的过敏反应严重程度减轻。